Medicine is moving up the central dogma of molecular biology. After 150 years of small molecules and 40 years of proteins, we are now in the era of nucleic acid medicines. These new modalities are now enabling us to aspire for curative therapies as opposed to managing disease. This talk will cover this evolution with examples of potential curative treatments for important diseases with significant unmet medical needs in genetic disease and oncology.